Page property search

This page provides a browsing interface for finding all values of a property and a given page. Other available search interfaces include the property search, and the ask query builder.

List of results

• A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)  +
• A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors  +
• A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma  +
• Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC  +
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)  +
• Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas  +
• Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women  +
• Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma  +
• Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation  +
• LAM561 With RT and TMZ for Adults With Glioblastoma  +
• Molecular Profiling of Advanced Soft-tissue Sarcomas  +
• OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC  +
• Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer  +
• Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection  +
• Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery  +
• SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients  +
• Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)  +
• Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast  +
• Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery  +
• Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer  +